News

Clinical Trials Arena on MSN1d
US FDA approves BlackfinBio’s gene therapy trial for hereditary spastic paraplegia
The US FDA has cleared BlackfinBio's application for a Phase I/II trial of BFB-101, an AAV gene therapy designed to treat ...
GEN - Genetic Engineering and Biotechnology News1d
New Upstream Method for Viral Capsid Analysis Using Mass Photometry
The researchers now plan to incorporate their new tool into a drug development program, leading to early clinical trials.
Machine learning model to predict the fitness of AAV capsids for gene therapy
A new study in Human Gene Therapy describes a machine learning (ML) model that can be used as a surrogate for laborious in ...
Spur Therapeutics Announces Oral and Poster Presentations Highlighting Data from Clinical and Preclinical Programs at Upcoming ASGCT Annual Meeting
Spur Therapeutics today announced that it will share new data from its gene therapy programs in Gaucher disease, GBA1 Parkinson’s disease and adrenomyeloneuropathy in oral and poster presentations at ...
Genprex Collaborators to Present Positive Preclinical Data on Diabetes Gene Therapy at the ASGCT 28th Annual Meeting
Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced ...
News-Medical.Net on MSN8d
Interferon regulatory factor 8 identified as key driver of liver fat buildup in NAFLD
Non-alcoholic fatty liver disease (NAFLD) is a hepatic metabolic syndrome resulting from lipid metabolic imbalance.